Latest filing published 24 Oct 2018 for PhaseBio Pharmaceuticals Inc.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Linda Tufts: trading record in brief
Linda Tufts appears in our data through filings on PhaseBio Pharmaceuticals Inc shares, published by SEC (Form 4). We count 6 filings, every one of them for a trade on 22 October 2018.
The open-market record is one-sided, with 3 purchases worth €87k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Half of the purchases are above €26k and half below. Clusters matter here: 3 out of 3 purchases overlapped with buying by a colleague within 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 24 October 2018: a transaction, in PhaseBio Pharmaceuticals Inc. The most recent open-market purchase was published on 24 October 2018, 2,938 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Linda Tufts
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 577,486 sharesCommon StockSEC:0001209191-18-056052:0
- 58,152 sharesCommon StockSEC:0001209191-18-056052:2
- 275,055 sharesCommon StockSEC:0001209191-18-056052:4
- 12,682 shares@ US$5.0063.4% of flowCommon StockSEC:0001209191-18-056052:1Canonical exit: 20 Jan 2019 (T+90)
- 1,277 shares@ US$5.006.4% of flowCommon StockSEC:0001209191-18-056052:3Canonical exit: 20 Jan 2019 (T+90)
- 6,041 shares@ US$5.0030.2% of flowCommon StockSEC:0001209191-18-056052:5Canonical exit: 20 Jan 2019 (T+90)
6 of 6 declarations